4//SEC Filing
Geffken Daniel E. 4
Accession 0001415889-21-005600
CIK 0001035354other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 11:06 AM ET
Size
5.0 KB
Accession
0001415889-21-005600
Insider Transaction Report
Form 4
Geffken Daniel E.
CHIEF FINANCIAL OFFICER
Transactions
- Purchase
Common Stock
2021-11-29$0.72/sh+50,000$36,000→ 50,000 total
Footnotes (1)
- [F1]Price represents the average purchase price per share.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001314756
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 11:06 AM ET
- Size
- 5.0 KB